Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Smoking cessation

Vaping comes out of the smoking closet

Use of e-cigarettes is becoming increasingly popular across the UK, and Public Health England now recommends they should be available on prescription.

Hand holding a cigarette and an e-cigarette

Source: Shutterstock.com

E-cigarettes are fast becoming the new statins — for every study supporting their benefits, there’s another to report the harm they could cause. And for every vaper sharing their stop-smoking success, another questions the real value of e-cigarettes as a smoking-cessation aid.

In January 2018, a Public Health England (PHE) review of e-cigarettes revealed its most positive stance by far on the use of e-cigarettes, and called for them to be made available on NHS prescription in England.

The review provided an update to a 2015 report, which concluded that vaping is 95% safer than smoking tobacco cigarettes. While vaping may never surpass effective psychological or pharmacological support approaches in helping people quit, PHE recommends vaping as another option for smokers who have not succeeded with other methods.

In an ideal world, all smokers would kick the habit entirely — when this is not possible, there are substantial health benefits associated with shunning the lethal cocktail of 7,000 compounds inhaled in tobacco smoke and switching to e-cigarettes. Many argue, however, that without data on the long-term effects of sustained vaping, it will be some time before we understand the full impact of e-cigarettes on health.

While the debate continues, the vaping trade is booming, with more than 2,000 stores popping up across the nation to cater for the estimated 2.9 million vapers in the UK.

And vaping shops are doing well in supporting customers with their quit attempts, according to a study published this month. The researchers at the University of East Anglia suggested that healthcare professionals could engage with reputable vaping shops, “to ensure best outcomes for clients wanting to use e-cigarettes to quit smoking”.

But should pharmacists themselves stock the devices? In a position statement published in 2014, the Royal Pharmaceutical Society (RPS) said that it “cannot support the sale of products with limited scientific evidence on safety”.

The RPS’s newly formed Science and Research Board of the RPS scheduled e-cigarettes for discussion during its inaugural meeting this month — perhaps, in light of new evidence and advice from experts in the field, it is an opportune time to review the Society’s stance.

PHE has called on the Medicines and Healthcare products Regulatory Agency to expedite the licensing of e-cigarettes as medicinal stop-smoking aids, and with their healthcare expertise, pharmacists are ideally placed to provide and advise on these products if the licences come to fruition.

While e-cigarettes wait to pass through regulation, pharmacists should equip themselves to discuss vaping with patients. In January 2018, The Pharmaceutical Journal distributed a handy guide produced by Cancer Research UK ‘What you need to know about e-cigarettes’, which also contains an A3 poster to display in the pharmacy.

In the interests of harm reduction — following a discussion of the limits of current knowledge on safety — e-cigarettes should be recommended to tobacco smokers who are unwilling to quit, or have failed to quit using other evidence-based approaches.

But until the uncertainty over the safety of e-cigarettes can be put to bed, pharmacists should continue to exercise their professional judgment in the recommendation and sale of e-cigarette products.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2018.20204427

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • BNF and BNF for Children

    BNF and BNF for Children

    Now available as a 1 year print subscription to both the BNF and BNFC, ensuring you have the latest medicines information as it publishes and at a greatly reduced price.

    £138.50Buy now
  • BNF and BNF for Children

    BNF and BNF for Children

    Now available as a 2 year print subscription to both the BNF and BNFC, ensuring you have the latest medicines information as it publishes and at a greatly reduced price.

    £262.50Buy now
  • Patient Care in Community Practice

    Patient Care in Community Practice

    Patient Care in Community Practice is a unique, practical guide for healthcare professionals or carers. Covers a range of non-medicinal products suitable for use at home.

    £22.00Buy now
  • Clinical Pharmacokinetics

    Clinical Pharmacokinetics

    A practical guide to the use of pharmacokinetic principles in clinical practice. Includes case studies with questions and answers.

    £33.00Buy now
  • Strategic Medicines Management

    Strategic Medicines Management

    A practical guide to influencing the availability of medicines, and policies of their use. Focuses on the strategic elements of medicines management.

    £33.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Hand holding a cigarette and an e-cigarette

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.